Publisher
Springer Berlin Heidelberg
Reference34 articles.
1. Aellig WH (1984) Investigation of the venoconstrictor effect of 8’hydroxydih ‘droergotamine, the main metabolite of dihydroergotamine, in man. Eur J Clin Pharmacol 26: 239–242
2. Aellig WH, Nüesch E (1977) Comparative pharmacokinetic investigations with tritium-labelled ergot alkaloids after oral and intravenous administration in man. Int J Clin Pharmacol 15: 106–112
3. Ala-Hurula V, Myllylä VV, Arvela P, Heikkilä J, Kärki N, Hokannen E (1979 a) Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration. Eur J Clin Pharmacol 15:51–55
4. Ala-Hurula V, Myllylä VV, Arvela P, Kärki N, Hokkanen E (1979 b) Systemic availability of ergotamine tartrate after three successive doses and during continuous medication. Eur J Clin Pharmacol 16:355–360
5. Andersen AR, Tfelt-Hansen P, Lassen NA (1987) The effect of ergotamine and dihydroergotamine on cerebral blood flow in man. Stroke 18: 120–123
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献